Transferrin-and folate-modified, double-targeted nanocarriers for gene delivery

Pharmaceutical Biology

Volumn 52, Issue 5, 2014, Pages 570-574

  Jing, Fanbo ^a   Li, Dongmei ^a   Xu, Wen ^a   Liu, Yujun ^a   Wang, Kai ^a   Sui, Zhongguo ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Active targeting system; Dual ligands modification; Gene therapy; Solid lipid nanoparticles

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FOLIC ACID; MACROGOL; PHOSPHATIDYLETHANOLAMINE; SOLID LIPID NANOPARTICLE; TRANSFERRIN; DIOLEOYL-N-(MONOMETHOXYPOLYETHYLENE GLYCOL SUCCINYL)PHOSPHATIDYLETHANOLAMINE; DNA; DRUG CARRIER; GREEN FLUORESCENT PROTEIN; LIGAND; MACROGOL DERIVATIVE; NANOPARTICLE; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; DRUG UPTAKE; FLOW CYTOMETRY; GENETIC TRANSFECTION; IN VIVO STUDY; LIGAND BINDING; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; SIGNAL TRANSDUCTION; SOLID TUMOR; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; GENE TRANSFER; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; MOLECULARLY TARGETED THERAPY; PLASMID; SURFACE PROPERTY;

ANIMALS; CELL SURVIVAL; DNA; DRUG CARRIERS; FLOW CYTOMETRY; FOLIC ACID; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HEP G2 CELLS; HUMANS; LIGANDS; LIVER NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; NANOPARTICLES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; POLYETHYLENE GLYCOLS; RECEPTORS, TRANSFERRIN; SURFACE PROPERTIES; TRANSFECTION; TRANSFERRIN;

EID: 84898462677     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.853812     Document Type: Article

References (26)

1. Atkinson H, Chalmers R. (2010). Delivering the goods: Viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences. Genetica 138:485-98.
2. Bellocq NC, Pun SH, Jensen GS, Davis ME. (2003). Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 14:1122-32.
3. Boulaiz H, Marchal JA, Prados J, et al. (2005). Non-viral and viral vectors for gene therapy. Cell Mol Biol (Noisy-le-grand) 51:3-22.
4. Choi JS, Ko KS, Park JS, et al. (2006). Dexamethasone conjugated poly(amidoamine) dendrimer as a gene carrier for efficient nuclear translocation. Int J Pharm 320:171-8.
5. Endres T, Zheng M, Beck-Broichsitter M, et al. (2012). Optimising the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation techniques. J Control Release 160:583-91.
6. Fields RJ, Cheng CJ, Quijano E, et al. (2012). Surface modified poly(b amino ester)-containing nanoparticles for plasmid DNA delivery. J Control Release 3659:00708-10.
7. Jing F, Li J, Liu D, et al. (2013). Dual ligands modified double targeted nano-system for liver targeted gene delivery. Pharm Biol 51:643-9.
8. Kim SK, Park KM, Singha K, et al. (2010). Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery. Chem Commun (Camb) 46:692-4.
9. Li P, Liu D, Miao L, et al. (2012). A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomed 7:925-39.
10. Liu C, Yu W, Chen Z, et al. (2011). Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveo-laemediated endocytosis. J Control Release 151:162-75.
11. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. (2002). Polyethylene glycoldiacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 19:1424-9.
12. Maruyama K. (2011). Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 63: 161-9.
13. Paulos CM, Reddy JA, Leamon CP, et al. (2004). Ligand binding and kinetics of folate receptor recycling in vivo: Impact on receptor-mediated drug delivery. Mol Pharmacol 66:1406-14.
14. Penate Medina O, Haikola M, Tahtinen M, et al. (2011). Liposomal tumor targeting in drug delivery utilizing MMP-2-and MMP-9-binding ligands. J Drug Deliv 2011:160515.
15. Pinti M, Troiano L, Nasi M, et al. (2003). Hepatoma HepG2 cells as a model for in vitro studies on mitochondrial toxicity of antiviral drugs: Which correlation with the patient? J Biol Regul Homeost Agents 17: 166-71.
16. Reddy JA, Abburi C, Hofland H, et al. (2002). Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther 9:1542-50.
17. Sawant RM, Hurley JP, Salmaso S, et al. (2006). "SMART" drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 17:943-9.
18. Singh M. (1999). Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 5:443-51.
19. Suzuki R, Takizawa T, Kuwata Y, et al. (2008). Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 346:143-50.
20. Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-60.
21. Torchilin VP. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532-55.
22. Torchilin VP. (2007) Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res 24:1-16.
23. van Vlerken LE, Vyas TK, Amiji MM. (2007). Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24:1405-14.
24. Yang L, Wang L, Su XQ, et al. (2010) Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin. Cancer Gene Ther 17: 49-57.
25. Yu W, Liu C, Liu Y, et al. (2010). Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 27:1584-96.
26. Zhao XB, Lee RJ. (2004) Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv Drug Deliv Rev 56:1193-204.